Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 66,650 clinical trials worldwide
Search
Showing 25201-25250 of 66,650 trials
Active filters:
Status: Recruiting
Clinical Trials (66,650)
NCT06182306
Prospective Evaluation of AI R&D Tool for Patient Stratification - MoA Evaluation in Triple Negative Breast Cancer (PEAR-MET)
N/A
Recruiting
30 participants
Started: Apr 30, 2024 · Completed: Jun 30, 2026
2 conditions
6 sponsors
3 locations
NCT06389279
The Effect of Facial Plane Blocks on Postoperative Recovery Quality in Hip Surgery
N/A
Recruiting
80 participants
Started: Apr 30, 2024 · Completed: Oct 24, 2024
1 condition
1 sponsor
1 location
NCT06464185
A Prospective Clinical Study of CD3-CD20 Bisspecific Antibody Based Therapy Combined With CD19-CAR T Cells in the Treatment of Relapsed Refractory B-cell Non-Hodgkin Lymphoma
PHASE1/PHASE2
Recruiting
48 participants
Started: Apr 30, 2024 · Completed: Apr 30, 2027
1 condition
1 sponsor
1 location
NCT06379399
Trifluridine/Tipiracil Combined With Cetuximab in the Treatment of Third-line and Above RAS/BRAF Wild-type mCRC
PHASE1/PHASE2
Recruiting
26 participants
Started: Apr 30, 2024 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT06367673
Natural Killer(NK) Cell Therapy Targeting CLL1 or CD33 in Acute Myeloid Leukemia
PHASE1
Recruiting
24 participants
Started: Apr 30, 2024 · Completed: Aug 31, 2026
1 condition
2 sponsors
1 location
NCT06345872
Improving Sleep and Reducing Opioid Use in Individuals With Chronic Pain
NA
Recruiting
165 participants
Started: Apr 30, 2024 · Completed: Jul 31, 2028
3 conditions
3 sponsors
1 location
NCT06321159
Investigation of the Effect of Mobile Software Use in Blood Pressure Management of Hypertensive Individuals on Quality of Life and Disease Self-Efficacy
NA
Recruiting
614 participants
Started: Apr 30, 2024 · Completed: Jan 30, 2026
1 condition
1 sponsor
1 location
NCT05946278
Genetic Regulators of Bone Health That Are Unique to Vertebral Bone
N/A
Recruiting
550 participants
Started: Apr 30, 2024 · Completed: Aug 30, 2030
1 condition
2 sponsors
1 location
NCT06300424
Neoadjuvant Almonertinib Followed by Chemo-immunotherapy in II-IIIB EGFR-mutant NSCLC
PHASE2
Recruiting
32 participants
Started: Apr 30, 2024 · Completed: Sep 30, 2027
2 conditions
1 sponsor
1 location
NCT06299228
Is Sensorimotor Training Effective Following a Distal Radius Fracture?
NA
Recruiting
50 participants
Started: Apr 30, 2024 · Completed: Apr 30, 2025
1 condition
3 sponsors
1 location
NCT06378671
Single-center Clinical Study on the Safety and Effect of Bronchoscopic Cryotherapy in Patients With Chronic Cough
NA
Recruiting
20 participants
Started: Apr 30, 2024 · Completed: Sep 30, 2024
1 condition
2 sponsors
1 location
NCT06292871
The Use of Social Media Platform to Continuously Support Pregnant Women With Gestational Diabetes Mellitus
NA
Recruiting
80 participants
Started: Apr 30, 2024 · Completed: Jun 30, 2025
1 condition
2 sponsors
1 location
NCT06397833
A Prospective, Observational, Single Centre Study to Assess the Feasibility of the Data Harvested by the Acorai Intracardiac Pressure Monitoring (ICPM) System in Predicting Prognosis in Patients Discharged From Hospital After Treatment for Acute Decompensated Heart Failure
N/A
Recruiting
150 participants
Started: Apr 29, 2024 · Completed: Feb 1, 2027
2 conditions
1 sponsor
1 location
NCT06374758
Accelerated ART Initiation for PWHIV Who Are Out of Care
PHASE4
Recruiting
120 participants
Started: Apr 29, 2024 · Completed: Nov 1, 2026
3 conditions
2 sponsors
4 locations
NCT06486506
Proximal Femur Reconstruction Following Resection of Primary Bone Tumors: Analysis of the Clinical and Radiographic Results
N/A
Recruiting
150 participants
Started: Apr 29, 2024 · Completed: Dec 31, 2025
2 conditions
1 sponsor
1 location
NCT06739499
Bern, Get Ready (BEready) Cohort Study for Pandemic Preparedness
N/A
Recruiting
2,500 participants
Started: Apr 29, 2024 · Completed: Dec 31, 2100
5 conditions
2 sponsors
1 location
NCT06389006
To Evaluate the Efficacy and Safety of Disitamab Vedotin Combined With Toripalimab Sequential Chemotherapy as Neoadjuvant Treatment in Patients With HR-positive, HER2-low Breast Cancer
PHASE2
Recruiting
79 participants
Started: Apr 29, 2024 · Completed: Dec 31, 2026
1 condition
1 sponsor
1 location
NCT06358872
Azithromycin for Child Survival in Niger II
PHASE4
Recruiting
3,300,000 participants
Started: Apr 29, 2024 · Completed: Apr 29, 2028
2 conditions
6 sponsors
1 location
NCT06217861
A Study to Evaluate the Tolerability, Safety and Efficacy of VGM-R02b
PHASE1
Recruiting
12 participants
Started: Apr 29, 2024 · Completed: Aug 31, 2026
2 conditions
1 sponsor
1 location
NCT06250985
New Treatment of Cardiac Device Infections; Immediate Reimplantation After Removal of Infected System
PHASE3
Recruiting
176 participants
Started: Apr 29, 2024 · Completed: Dec 31, 2037
1 condition
1 sponsor
1 location
NCT06294236
Study Evaluating SC291 in Subjects With Severe r/r B-cell Mediated Autoimmune Diseases (GLEAM)
PHASE1
Recruiting
36 participants
Started: Apr 29, 2024 · Completed: Mar 31, 2028
6 conditions
1 sponsor
5 locations
NCT06212817
Dietary Fiber Before Colorectal Cancer Surgery
NA
Recruiting
54 participants
Started: Apr 29, 2024 · Completed: Dec 31, 2025
1 condition
7 sponsors
1 location
NCT06385925
A Study of TSN1611 Treating Patients With Advanced Solid Tumors Harboring KRAS G12D Mutation
PHASE1/PHASE2
Recruiting
150 participants
Started: Apr 29, 2024 · Completed: Apr 30, 2027
1 condition
1 sponsor
6 locations
NCT06410599
Pharmacologic Treatment Augmentation in Chronic Depression
PHASE2
Recruiting
60 participants
Started: Apr 29, 2024 · Completed: Jul 31, 2026
1 condition
2 sponsors
2 locations
NCT06394804
A Study of Avutometinib, Defactinib, and Letrozole in People With Low-Grade Serous Ovarian Cancer
PHASE2
Recruiting
20 participants
Started: Apr 29, 2024 · Completed: Apr 30, 2027
1 condition
2 sponsors
8 locations
NCT06338995
A Study of Lebrikizumab (LY3650150) in Adult Participants With Chronic Rhinosinusitis and Nasal Polyps Treated With Intranasal Corticosteroids (CONTRAST-NP)
PHASE3
Recruiting
510 participants
Started: Apr 29, 2024 · Completed: Mar 31, 2028
1 condition
1 sponsor
174 locations
NCT06188702
S095035 as a Single Agent and in Combination in Adult Participants With Advanced or Metastatic Solid Tumors With Deletion of MTAP
PHASE1/PHASE2
Recruiting
308 participants
Started: Apr 29, 2024 · Completed: Oct 31, 2031
1 condition
3 sponsors
32 locations
NCT06457815
Iron Deficiency in Acute Myocardial Infarction: Prevalence Pilot Study
N/A
Recruiting
70 participants
Started: Apr 29, 2024 · Completed: Aug 30, 2024
1 condition
1 sponsor
2 locations
NCT06398665
Accelerated, Theta-burst Stimulation for the Treatment of Post-concussion Syndrome - Open-label Pilot Study
NA
Recruiting
10 participants
Started: Apr 29, 2024 · Completed: Mar 31, 2026
1 condition
1 sponsor
1 location
NCT06447233
Patient Perspectives Medicaid Title XIX Sterilization Consent Form
N/A
Recruiting
100 participants
Started: Apr 29, 2024 · Completed: Apr 30, 2026
1 condition
2 sponsors
1 location
NCT06648863
Bahir Dar Child Development Study, Ethiopia
N/A
Recruiting
400 participants
Started: Apr 29, 2024 · Completed: Apr 30, 2025
2 conditions
4 sponsors
1 location
NCT06374225
Strategy to Avoid Excessive Oxygen Using an Autonomous Oxygen Titration Intervention
NA
Recruiting
300 participants
Started: Apr 29, 2024 · Completed: May 1, 2026
4 conditions
4 sponsors
4 locations
NCT06346067
A Study to Assess Naporafenib (ERAS-254) Administered With Trametinib in Patients With NRAS-mutant Melanoma (SEACRAFT-2)
PHASE3
Recruiting
470 participants
Started: Apr 29, 2024 · Completed: Dec 31, 2028
1 condition
1 sponsor
59 locations
NCT06237127
Effects of Goji vs. Fiber on Macular Degeneration
NA
Recruiting
60 participants
Started: Apr 29, 2024 · Completed: Jun 30, 2027
1 condition
2 sponsors
1 location
NCT06410261
Exercise Rehabilitation Program in MS Who Use Wheelchairs as a Primary Mobility Device
NA
Recruiting
24 participants
Started: Apr 29, 2024 · Completed: Jul 31, 2027
1 condition
1 sponsor
1 location
NCT06247319
Study to Evaluate the Effectiveness of Risankizumab in Participants With a Recent Diagnosis of Moderate Plaque Psoriasis in a Real-life Setting in Greece
N/A
Recruiting
250 participants
Started: Apr 29, 2024 · Completed: Oct 31, 2027
3 conditions
1 sponsor
22 locations
NCT06649994
Transcranial Magnetic Stimulation and Inhibitory Control Training to Reduce Binge Eating: Brain and Behavioral Changes
NA
Recruiting
150 participants
Started: Apr 29, 2024 · Completed: Dec 31, 2026
2 conditions
2 sponsors
1 location
NCT06370962
Circadian Rhythm Disorders in Children With Cystic Fibrosis Under CFTR (Cystic Fibrosis Transmembrane Conductance Regulator) Modulators
N/A
Recruiting
180 participants
Started: Apr 29, 2024 · Completed: Jan 29, 2026
1 condition
1 sponsor
3 locations
NCT06365684
Sodium Zirconium Cyclosilicate to Allow Liberal Fruit and Vegetable Intake for Patients With CKD Stage 3b and 4
PHASE4
Recruiting
16 participants
Started: Apr 29, 2024 · Completed: May 1, 2025
4 conditions
2 sponsors
1 location
NCT05909709
Dose Escalation Pilot Study to Evaluate the Safety of Alocyte for the Treatment of Facetogenic Back Pain
PHASE1
Recruiting
15 participants
Started: Apr 29, 2024 · Completed: Oct 1, 2026
3 conditions
1 sponsor
1 location
NCT06740994
Ultrasound Guided Midline vs Landmark Paramedian Continous Spinal Anesthesia in the Elderly
NA
Recruiting
110 participants
Started: Apr 29, 2024 · Completed: Aug 31, 2025
1 condition
1 sponsor
1 location
NCT06979999
The Effects of Positive End-expiratory Pressure (PEEP) on Optic Nerve Sheath Diameter in Laparoscopic Cholecystectomy
NA
Recruiting
50 participants
Started: Apr 29, 2024 · Completed: Jul 29, 2025
4 conditions
1 sponsor
1 location
NCT06523478
Intratonsillar Immunotherapy for Allergic Rhinitis
NA
Recruiting
120 participants
Started: Apr 29, 2024 · Completed: Apr 29, 2028
1 condition
1 sponsor
1 location
NCT06272110
Promoting Equitable Access to Language Services in Health and Human Services
N/A
Recruiting
17,500 participants
Started: Apr 29, 2024 · Completed: Aug 31, 2026
1 condition
2 sponsors
3 locations
NCT06350097
Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer
PHASE3
Recruiting
582 participants
Started: Apr 29, 2024 · Completed: May 25, 2032
1 condition
2 sponsors
163 locations
NCT06698341
UNdeRstAnding Novel Variants in AcutE MyocardiaL Infarction in Young Adults
N/A
Recruiting
1,200 participants
Started: Apr 29, 2024 · Completed: Apr 30, 2028
1 condition
1 sponsor
1 location
NCT06251297
Feasibility and Benefits of Reflexology in the Prevention of Neuropathy Induced by Oxaliplatin in Colorectal Cancer
NA
Recruiting
40 participants
Started: Apr 29, 2024 · Completed: Dec 31, 2026
1 condition
1 sponsor
1 location
NCT06478056
Correlation of Portal and Peripheral Venous ctDNA in Pancreatic Adenocarcinoma
NA
Recruiting
30 participants
Started: Apr 29, 2024 · Completed: Apr 29, 2026
1 condition
1 sponsor
1 location
NCT06410339
Ultrasound Assessment of Anatomical Changes in the Fingers of Recreational Rock Climbers
N/A
Recruiting
50 participants
Started: Apr 29, 2024 · Completed: May 1, 2025
1 condition
1 sponsor
1 location
NCT06539182
DZD8586 in Patients With Relapsed or Refractory CLL/SLL (TAI-SHAN8)
PHASE2
Recruiting
155 participants
Started: Apr 29, 2024 · Completed: Mar 31, 2028
1 condition
1 sponsor
17 locations
Previous
1
More pages
502
503
504
505
506
507
508
More pages
1333
Next